The Bill and Melinda Gates Foundation has partnered with SA institutions to develop new medicines and vaccines for HIV, TB and malaria.

South Africa's ambitions of producing its own antiretroviral (ARV), malaria and tuberculosis drugs have taken a knock, with its private sector partner, Lonza Pharmaceuticals, pulling out of Ketlaphela, the public-private partnership intended to produce local ingredients for pharmaceuticals.